Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Evaluating a precision medicine approach to nephrotic syndrome using novel genetic risk profiles: A pilot adaptive clinical trial
FY 2021-22
Summary
Nephrotic syndrome is one of the most common childhood kidney diseases. It is diagnosed in up to 3,000 Canadian children each year. In nephrotic syndrome, the kidneys leak protein into the urine, which decreases the amount of protein in the blood, and causes swelling of the body. This can cause breathing problems, infections, and blood clots. The cause of nephrotic syndrome is unknown, but we think that genetic differences and the immune system are involved. Most children respond to steroid treatment, but many have frequent disease relapses. These children receive lots of steroids and other medications to suppress the immune system. These have many side effects, and every child responds differently to treatment. We still dont know what the best medications are to treat nephrotic syndrome. And we dont have tools to predict which children will respond to medications. Creating these tools could reduce the number of medications tried, prevent side effects, and get children to respond to treatment sooner.Using genetic information from over 750 children with and without nephrotic syndrome, we are creating a prediction tool to identify which children will develop severe disease and which will respond to different treatments. The goal of this research is to learn whether using this genetic prediction tool to make treatment decisions is better than current treatment without the tool. To do so, we will first perform a ;pilot study in a small number of children with nephrotic syndrome in Toronto, to ensure that our research is feasible and safe. If this genetic prediction tool is effective, it will allow doctors to use a ;precision medicine approach to treat childhood nephrotic syndrome. This can improve the care of these children and reduce disease complications.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466596
Name
Robinson Cal
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating a precision medicine approach to nephrotic syndrome using novel genetic risk profiles: A pilot adaptive clinical trial
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adaptive Clinical Trial; Bayesian; Genetic Polymorphisms; Kidney Disease; Nephrotic Syndrome; Pediatric Nephrology; Precision Medicine
Abstract
Nephrotic syndrome is one of the most common childhood kidney diseases. It is diagnosed in up to 3,000 Canadian children each year. In nephrotic syndrome, the kidneys leak protein into the urine, which decreases the amount of protein in the blood, and causes swelling of the body. This can cause breathing problems, infections, and blood clots. The cause of nephrotic syndrome is unknown, but we think that genetic differences and the immune system are involved. Most children respond to steroid treatment, but many have frequent disease relapses. These children receive lots of steroids and other medications to suppress the immune system. These have many side effects, and every child responds differently to treatment. We still dont know what the best medications are to treat nephrotic syndrome. And we dont have tools to predict which children will respond to medications. Creating these tools could reduce the number of medications tried, prevent side effects, and get children to respond to treatment sooner.Using genetic information from over 750 children with and without nephrotic syndrome, we are creating a prediction tool to identify which children will develop severe disease and which will respond to different treatments. The goal of this research is to learn whether using this genetic prediction tool to make treatment decisions is better than current treatment without the tool. To do so, we will first perform a ;pilot study in a small number of children with nephrotic syndrome in Toronto, to ensure that our research is feasible and safe. If this genetic prediction tool is effective, it will allow doctors to use a ;precision medicine approach to treat childhood nephrotic syndrome. This can improve the care of these children and reduce disease complications.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Robinson, Cal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~